![Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions - Clinical Oncology Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions - Clinical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/7fad3e09-6cf2-44bd-8bf9-9ba6473719db/gr1_lrg.jpg)
Radiotherapy Trial Set-up in the UK: Identifying Inefficiencies and Potential Solutions - Clinical Oncology
![Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial - International Journal of Radiation Oncology, Biology, Physics Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/855770/6254544/gr1.jpg)
Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of Phase III clinical trial - International Journal of Radiation Oncology, Biology, Physics
![Practice-changing clinical trials in radiotherapy and imaging - The Institute of Cancer Research, London Practice-changing clinical trials in radiotherapy and imaging - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/default-album/mri-scanner---embed.jpg?sfvrsn=9e127e69_0)
Practice-changing clinical trials in radiotherapy and imaging - The Institute of Cancer Research, London
![The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform - Clinical Oncology The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform - Clinical Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/81c845c2-57c6-44d2-a515-8a9067d2fb3d/gr1.jpg)
The UK at the Forefront of Innovative Drug–Radiotherapy Combination Clinical Trials: Introducing the CONCORDE Platform - Clinical Oncology
![Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter? - Radiotherapy and Oncology Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter? - Radiotherapy and Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/21c0c05d-c46a-4c7e-8505-297b768ec9c6/gr1_lrg.jpg)
Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter? - Radiotherapy and Oncology
![Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial - The Lancet Oncology Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1b7ffc68-59e9-484e-b702-4cf9b9c61163/gr1_lrg.jpg)
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial - The Lancet Oncology
![Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) - The Lancet Oncology Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) - The Lancet Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005797054/2025324760/gr1.gif)
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) - The Lancet Oncology
![PMB-Alcen Announces the Launch of FLASHKNiFE, the FLASH Radiotherapy System Dedicated to Clinical Trials - PR Newswire APAC PMB-Alcen Announces the Launch of FLASHKNiFE, the FLASH Radiotherapy System Dedicated to Clinical Trials - PR Newswire APAC](https://mma.prnasia.com/media2/1194007/3d_device_image.jpg?p=publish)
PMB-Alcen Announces the Launch of FLASHKNiFE, the FLASH Radiotherapy System Dedicated to Clinical Trials - PR Newswire APAC
![Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial - International Journal of Radiation Oncology, Biology, Physics Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial - International Journal of Radiation Oncology, Biology, Physics](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2f5bcc17-e5db-4dd6-b13e-7f075b3612f0/gr1.jpg)
Intratumoral Hydrogen Peroxide With Radiation Therapy in Locally Advanced Breast Cancer: Results From a Phase 1 Clinical Trial - International Journal of Radiation Oncology, Biology, Physics
![The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members - Annals of Oncology The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/37d0bc70-acb5-4707-ae1a-1181c0971da5/gr1_lrg.jpg)
The reporting of adverse events in oncology phase III trials: a comparison of the current status versus the expectations of the EORTC members - Annals of Oncology
![Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature - ScienceDirect Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0936655520303988-gr1.jpg)
Structure and Processes of Existing Practice in Radiotherapy Peer Review: A Systematic Review of the Literature - ScienceDirect
Clinical Trial of Prophylactic Extended-Field Carbon-Ion Radiotherapy for Locally Advanced Uterine Cervical Cancer (Protocol 0508) | PLOS ONE
![AQUILAB on Twitter: "We are pleased to invite you to join our webinar on November 24 at 11:00 am CET on “Radiotherapy quality assurance (RT QA) in clinical trials”. More information and AQUILAB on Twitter: "We are pleased to invite you to join our webinar on November 24 at 11:00 am CET on “Radiotherapy quality assurance (RT QA) in clinical trials”. More information and](https://pbs.twimg.com/media/EmZQ_2CXMAMIJKx.jpg)